BOSTON, Jan. 13 /PRNewswire/ -- Johnston Blakely & Company, LLC, a Boston-based life science investment bank, is pleased to announce that Michael D. Webb has joined the firm as senior advisor. In this role, Mr. Webb will participate with the firm on internal and client-related activities including merger & acquisition advisory services and private equity placements, with a particular focus on biopharmaceutical transactions. "We are delighted to have someone of Mike's caliber join the Johnston Blakely team," said Johnston Blakely founder Benjamin Conway. "His extensive senior management experience and depth of sector knowledge will be of tremendous value to both the firm and its clients."
Mr. Webb was previously President & CEO of EPIX Pharmaceuticals where he
completed over $225 million in financings, including its 1997 IPO, and raised
an additional $150 million through corporate partnerships. Prior to EPIX, Mr.
Webb was Senior Vice President, Worldwide Marketing and Strategic Planning for
Ciba Diagnostics. Most recently he has been active with Ascent Therapeutics
where as founder, president & CEO he organized the company and secured its
initial $20 million in venture financing. Mr. Webb holds an M.B.A. with
highest honors from
About Johnston Blakely & Company
Johnston Blakely & Company, LLC is a Boston-based investment bank offering merger & acquisition-related financial advisory and private equity placement services to companies in the life science sector. The firm incorporates the venture capital tradition of comprehensive company involvement into investment banking engagements to deliver superior results for its clients. More than investment banking...inVenture banking(TM).
Johnston Blakely is a registered broker/dealer and member of FINRA/SIPC.
|SOURCE Johnston Blakely & Company, LLC|
Copyright©2009 PR Newswire.
All rights reserved